Every open market buy and sale of Merck & Co., Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $79.3M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when MRK insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an MRK officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every MRK insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Richard R. DeLucaEVP&Pres, Merck Animal Heallth | Sale | 58,185 | $148.01 | $8.6M | 112,955 | Nov 16Form 4 |
| Aug 13, 2026 | Chirfi GuindoEVP, Access, Policy & Comms | Sale | 10,000 | $135.00 | $1.4M | 36,613 | Aug 13Form 4 |
| Aug 12, 2026 | Jennifer ZacharyEVP, General Counsel | Sale | 80,315 | $133.46 | $10.7M | 45,509 | Aug 13Form 4 |
| Aug 12, 2026 | Richard R. DeLucaEVP&Pres, Merck Animal Heallth | Sale | 45,320 | $131.12 | $5.9M | 110,167 | Aug 12Form 4 |
| Aug 6, 2026 | Richard R. DeLucaEVP&Pres, Merck Animal Heallth | Sale | 6,050 | $130.38 | $789K | 155,487 | Aug 10Form 4 |
| Aug 6, 2026 | Chirfi GuindoEVP, Access, Policy & Comms | Sale | 15,000 | $131.00 | $2M | 46,613 | Aug 7Form 4 |
| Aug 5, 2026 | David Michael WilliamsEVP,Chief Info&Digital Officer | Sale | 52,847 | $128.77 | $6.8M | 31,716 | Aug 7Form 4 |
| Aug 5, 2026 | David R. MaraldoEVP & Pres. MMD | Sale | 18,706 | $128.72 | $2.4M | 18,212 | Aug 7Form 4 |
| Feb 12, 2026 | Chirfi GuindoChief Marketing Officer | Sale | 10,000 | $121.46 | $1.2M | 60,615 | Feb 12Form 4 |
| Feb 10, 2026 | Dean Y LiExecutive VP & President, MRL | Sale | 10,235 | $117.52 | $1.2M | 92,035 | Feb 10Form 4 |
| Feb 9, 2026 | Jennifer ZacharyEVP, General Counsel | Sale | 121,573 | $119.15 | $14.5M | 68,916 | Feb 9Form 4 |
| Feb 9, 2026 | Chirfi GuindoChief Marketing Officer | Sale | 10,000 | $118.41 | $1.2M | 70,615 | Feb 9Form 4 |
| Feb 6, 2026 | Richard R. DeLucaEVP&Pres, Merck Animal Heallth | Sale | 37,685 | $120.92 | $4.6M | 160,174 | Feb 6Form 4 |
| Feb 6, 2026 | Johannes Jacobus OosthuizenPresident, U.S. Market | Sale | 15,000 | $121.87 | $1.8M | 21,197 | Feb 6Form 4 |
| Feb 6, 2026 | David Michael WilliamsEVP,Chief Info&Digital Officer | Sale | 5,000 | $121.91 | $610K | 30,838 | Feb 6Form 4 |
MRK insider trading FAQ
Are MRK insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of MRK on the open market in 0 trades, and 10 sold $79.3M in 20 trades.
When did an MRK insider last buy shares?
Inge G Thulin (Director) bought 2,833 shares for $250K on Feb 6, 2025, reported on Feb 7, 2025.
When did an MRK insider last sell shares?
Richard R. DeLuca (EVP&Pres, Merck Animal Heallth) sold 58,185 shares for $8.6M on Nov 12, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
